Category: Drug Development
Global Drug Development
-
Glioblastoma Multiforme (GBM) Treatment Market Share, Size, Trends, Industry Analysis Report, By Treatment (Surgery, Radiation therapy, Chemotherapy, Targeted Therapy, Tumor Treating Field (TTF) Therapy, and Immunotherapy), By Drug Class (Temozolomide, Bevacizumab, Lomustine, Carmustine Wafers, and Others), By End-Use, By Region; Segment Forecast, 2022 - 2030
... Others), By End-Use, By Region; Segment Forecast, 2022 - 2030 The global glioblastoma multiforme (GBM) treatment market size is expected to reach USD 4.82 billion by 2030 according to a new study by Polaris Market ... Read More
-
The Global Market for Advanced Fibers 2022-2032
... energy storage and generation (solar cells, lithium batteries, supercapacitor, etc.) biomedical applications (regenerative medicine, drug delivery, tumor therapy, etc) Their use will increase greatly in these and other markets in the next 10-15 years. ... Read More
-
Biosimulation Market Share, Size, Trends, Industry Analysis Report, By Product (Software, Services), By Application (Drug Development, Drug Discovery, Others), By End-Use, By Region; Segment Forecast, 2022 - 2030
... to reach USD 8.65 billion by 2030 according to a new study by Polaris Market Research. The report “Biosimulation Market Share, Size, Trends, Industry Analysis Report, By Product (Software, Services), By Application (Drug Development, Drug ... Read More
-
Artificial Intelligence (AI) in Pharmaceutical Market Share, Size, Trends, Industry Analysis Report, By Application (Drug Discovery, Precision Medicine, Medical Imaging & Diagnostics, Research); By Technology; By Offering; By Deployment; By Region; Segment Forecast, 2022 - 2029
... 2029 The global Artificial Intelligence (AI) in pharmaceutical market size is expected to reach USD 7,147.2 million by 2029 according to a new study by Polaris Market Research. The report “Artificial Intelligence (AI) in Pharmaceutical ... Read More
-
Global Cancer Immunotherapy Market Analysis & Forecast to 2025 Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor (CAR) T-Cell Therapy, PD-1/PD-L1 inhibitors, Dendritic Cells, Checkpoint Inhibitors, Adopted Cell Therapy (ACT) & IDO Inhibitors
... (ACT) & IDO Inhibitors Within the cancer therapeutics space, which today is worth over $160 billion globally, immunotherapeutic drugs have gained worldwide acceptance. This is because they are targeted therapeutics that have high specificity for ... Read More
-
Global Biosimulation - Market and Technology Forecast to 2028
... impairment to the human body. This feature of biosimulation is extensively used while designing drugs to cure illnesses. Biosimiluation helps quantify if a drug will be harmful to the human body with regards to toxicity ... Read More
-
Outsourcing in Drug Discovery, 9th Edition
... cost-cutting strategy that can also improve the hit-to-lead conversion and early identification of unsuccessful compounds. In view of the fact that outsourcing can accelerate the drug discovery process, the business of contract drug discovery has ... Read More
-
Downstream Bioprocessing Markets (Chromatography Columns and Resins, Membrane Adsorbers, Filtration Systems, Sensors)
... plant tissue or fermentation broth. It is an essential step in producing pharmaceuticals, such as antibiotics, hormones (insulin and human growth hormone), antibodies, and vaccines. Downstream Bioprocessing Markets analyzes the current and potential world market ... Read More
Research Assistance
